腎細胞癌における5-アミノレブリン酸(5-ALA)を用いた光力学診断および5-ALA投与後の尿中ポルフィリン測定の有用性の検討

5-アミノレブリン酸(ALA)の代謝産物であるプロトポルフィリンIX(PPIX)は正常組織に比べ腫瘍組織に高濃度に集積し,青色光で赤色の蛍光を発する.この特性を利用した癌の蛍光診断を光力学診断(Photodynamic Diagnosis: PDD)と呼ぶ.膀胱癌においては,5-ALA投与後の腫瘍の発光程度と悪性度に相関関係があることや,5-ALA投与後の尿中ポルフィリン値がその診断に有用であると報告されている.しかし,腎細胞癌においては,そのような研究報告はない.本研究においては,腎細胞癌における5-ALAの診断に関する有用性について検討したので報告する....

Full description

Saved in:
Bibliographic Details
Published in日本レーザー医学会誌 Vol. 40; no. 1; pp. 93 - 103
Main Authors 城武, 卓, 小山, 政史, 岡部, 尚志, 西本, 紘嗣郎, 安田, 政実
Format Journal Article
LanguageJapanese
Published 特定非営利活動法人 日本レーザー医学会 15.04.2019
Subjects
Online AccessGet full text
ISSN0288-6200
1881-1639
DOI10.2530/jslsm.jslsm-40_0014

Cover

Abstract 5-アミノレブリン酸(ALA)の代謝産物であるプロトポルフィリンIX(PPIX)は正常組織に比べ腫瘍組織に高濃度に集積し,青色光で赤色の蛍光を発する.この特性を利用した癌の蛍光診断を光力学診断(Photodynamic Diagnosis: PDD)と呼ぶ.膀胱癌においては,5-ALA投与後の腫瘍の発光程度と悪性度に相関関係があることや,5-ALA投与後の尿中ポルフィリン値がその診断に有用であると報告されている.しかし,腎細胞癌においては,そのような研究報告はない.本研究においては,腎細胞癌における5-ALAの診断に関する有用性について検討したので報告する.
AbstractList 5-アミノレブリン酸(ALA)の代謝産物であるプロトポルフィリンIX(PPIX)は正常組織に比べ腫瘍組織に高濃度に集積し,青色光で赤色の蛍光を発する.この特性を利用した癌の蛍光診断を光力学診断(Photodynamic Diagnosis: PDD)と呼ぶ.膀胱癌においては,5-ALA投与後の腫瘍の発光程度と悪性度に相関関係があることや,5-ALA投与後の尿中ポルフィリン値がその診断に有用であると報告されている.しかし,腎細胞癌においては,そのような研究報告はない.本研究においては,腎細胞癌における5-ALAの診断に関する有用性について検討したので報告する.
Author 安田, 政実
城武, 卓
岡部, 尚志
小山, 政史
西本, 紘嗣郎
Author_xml – sequence: 1
  fullname: 城武, 卓
  organization: 埼玉医科大学国際医療センター 泌尿器腫瘍科
– sequence: 1
  fullname: 小山, 政史
  organization: 埼玉医科大学国際医療センター 泌尿器腫瘍科
– sequence: 1
  fullname: 岡部, 尚志
  organization: 埼玉医科大学国際医療センター 泌尿器腫瘍科
– sequence: 1
  fullname: 西本, 紘嗣郎
  organization: 埼玉医科大学国際医療センター 泌尿器腫瘍科
– sequence: 1
  fullname: 安田, 政実
  organization: 埼玉医科大学国際医療センター 病理診断科
BookMark eNo9kMtKw1AQhg-iYK0-gc8QnZPkpCfLIt6g4Kb7cNIm2lKrNG7cmRwLtkpBUcE7eC1qRdBFEdGHmSatK1_Btoqbf2bg5xv4RshgcaXoEDJOYUJlGkzmvYK3PNFPRQcLgOoDJEY5pwo1NHOQxEDlXDFUgGEy5nk5G4CZQLmRiJGbTrnWfn3uyPP20Q76D-hX0d_FYJspGFyivEBZQ_mI8hDlPcqXr3Lz-32LKclU8vu9gsFee7-O_ib6F2G5ElZPwsZtp_4WHTZ6oGAL_Zd-N6oetJq18KP74il8_mw1GyjPUD6gPMDg6hcdNR_Dp-NuITqtdKnRxl1vvz7t1GujZMgVBc8Z-5txkp6ZTk_NKamF2fmpZErJU24KRTMSXHMN1aScJWxgTGRU3bVdDewsEy7nYFBdCKrbDtOzAIZq6HZWOOCYDLimxcn8LzbvrYlFx1ot5ZZFad0SpbVcpuBYfcdW1zHtxf_VM_7fySyJkpUX2g-Q9rPo
ContentType Journal Article
Copyright 2019 特定非営利活動法人 日本レーザー医学会
Copyright_xml – notice: 2019 特定非営利活動法人 日本レーザー医学会
DOI 10.2530/jslsm.jslsm-40_0014
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1881-1639
EndPage 103
ExternalDocumentID article_jslsm_40_1_40_jslsm_40_0014_article_char_ja
GroupedDBID 2WC
ABJNI
ALMA_UNASSIGNED_HOLDINGS
CS3
JSF
KQ8
MOJWN
OK1
RJT
ID FETCH-LOGICAL-j189a-36783f6291857b055ac24fbf30bd5af880614aa14be54d006264bdae0e950833
ISSN 0288-6200
IngestDate Wed Sep 03 06:20:44 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 1
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j189a-36783f6291857b055ac24fbf30bd5af880614aa14be54d006264bdae0e950833
OpenAccessLink https://www.jstage.jst.go.jp/article/jslsm/40/1/40_jslsm-40_0014/_article/-char/ja
PageCount 11
ParticipantIDs jstage_primary_article_jslsm_40_1_40_jslsm_40_0014_article_char_ja
PublicationCentury 2000
PublicationDate 2019/04/15
PublicationDateYYYYMMDD 2019-04-15
PublicationDate_xml – month: 04
  year: 2019
  text: 2019/04/15
  day: 15
PublicationDecade 2010
PublicationTitle 日本レーザー医学会誌
PublicationTitleAlternate 日レ医誌
PublicationYear 2019
Publisher 特定非営利活動法人 日本レーザー医学会
Publisher_xml – name: 特定非営利活動法人 日本レーザー医学会
References 1) 小山, 政史,朝倉 博孝,上野 宗久.5-アミノレブリン酸を用いた光線力学的診断・治療.臨床泌尿器科.2010; 64: 967-977.
7) Nakai Y, Anai S, Onishi S, Masaomi K, Tatsumi Y, Miyake M, Chihara Y, Tanaka N, Hirao Y, Fujimoto K. Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer. Photodiagnosis Photodyn Ther. 2015; 12: 282-288.
3) Schoenfeld N, Mamet R, Leibovici L, Epstein O, Teitz Y, Atsmon A. Growth rate determines activity of porphobilinogen deaminase both in nonmalignant and malignant cell lines. Biochem Med Metab Biol. 1988; 40: 213-217.
5) Nakai Y, Tatsumi Y, Miyake M, Anai S, Kuwada M, Onishi S, Chihara Y, Tanaka N, Hirao Y, Fujimoto K. Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancer. Photodiagnosis Photodyn Ther. 2016; 13: 225-232.
14) Peng C, Li Y, Liang H, Cheng J, Li Q, Sun X, Li Z, Wang F, Guo Y, Tian Z, Yang L, Tian Y, Zhang Z, Cao W. Detection and photodynamic therapy of inflamed atherosclerotic plaques in the carotid artery of rabbits. J Photochem Photobiol B. 2011; 102: 26-31.
4) Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992; 14: 275-292.
11) Kondo H, Shirotake S, Okabe T, Makino S, Nishimoto K, Oyama M. Clinical Impact of Consolidative and Salvage Radiotherapy for Lymph Node Metastasis in Upper Urinary Tract Urothelial Carcinoma. Case Rep Urol. 2018; 2018: 1471839.
10) Endo Y, Okayama A, Endo G, Ueda T, Nakazono N, Horiguchi S. Improvement of urinary delta-aminolevulinic acid determination by HPLC and fluorescence detection using condensing reaction with acetylacetone and formaldehyde. Sangyo Igaku. 1994; 36: 49-56.
15) Kirdaite G, Lange N, Busso N, Van Den Bergh H, Kucera P, So A. Protoporphyrin IX photodynamic therapy for synovitis. Arthritis Rheum. 2002; 46: 1371-1378.
6) Inoue K, Ota U, Ishizuka M, Kawada C, Fukuhara H, Shuin T, Okura I, Tanaka T, Ogura S. Porphyrins as urinary biomarkers for bladder cancer after 5-aminolevulinic acid (ALA) administration: the potential of photodynamic screening for tumors. Photodiagnosis Photodyn Ther. 2013; 10: 484-489.
8) Hoda MR, Popken G. Surgical outcomes of fluorescence-guided laparoscopic partial nephrectomy using 5-aminolevulinic acid-induced protoporphyrin IX. J Surg Res. 2009; 154: 220-225.
12) Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ, Ruether JD, Cheng T, North S, Venner P, Knox JJ, Chi KN, Kollmannsberger C, McDermott DF, Oh WK, Atkins MB, Bukowski RM, Rini BI, Choueiri TK. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J Clin Oncol. 2009; 27: 5794-5799.
2) 西本, 紘嗣郎,城 武卓,小山, 政史.5-アミノレブリン酸を用いた診断への取り組み(第45回尿路悪性腫瘍研究会講演スライド,2018年7月21日).2018. Available from: https://figshare.com/articles/5-________/7075235.
13) Tickoo SK, Lee MW, Eble JN, Amin M, Christopherson T, Zarbo RJ, Amin MB. Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol. 2000; 24: 1247-1256.
9) Kamada Y, Murayama Y, Ota U, Takahashi K, Arita T, Kosuga T, Konishi H, Morimura R, Komatsu S, Shiozaki A, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Tanaka T, Otsuji E. Urinary 5-Aminolevulinic Acid Concentrations as a Potential Tumor Marker for Colorectal Cancer Screening and Recurrence. Anticancer Res. 2016; 36: 2445-2450.
References_xml – reference: 12) Heng DY, Xie W, Regan MM, Warren MA, Golshayan AR, Sahi C, Eigl BJ, Ruether JD, Cheng T, North S, Venner P, Knox JJ, Chi KN, Kollmannsberger C, McDermott DF, Oh WK, Atkins MB, Bukowski RM, Rini BI, Choueiri TK. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study. J Clin Oncol. 2009; 27: 5794-5799.
– reference: 1) 小山, 政史,朝倉 博孝,上野 宗久.5-アミノレブリン酸を用いた光線力学的診断・治療.臨床泌尿器科.2010; 64: 967-977.
– reference: 3) Schoenfeld N, Mamet R, Leibovici L, Epstein O, Teitz Y, Atsmon A. Growth rate determines activity of porphobilinogen deaminase both in nonmalignant and malignant cell lines. Biochem Med Metab Biol. 1988; 40: 213-217.
– reference: 15) Kirdaite G, Lange N, Busso N, Van Den Bergh H, Kucera P, So A. Protoporphyrin IX photodynamic therapy for synovitis. Arthritis Rheum. 2002; 46: 1371-1378.
– reference: 11) Kondo H, Shirotake S, Okabe T, Makino S, Nishimoto K, Oyama M. Clinical Impact of Consolidative and Salvage Radiotherapy for Lymph Node Metastasis in Upper Urinary Tract Urothelial Carcinoma. Case Rep Urol. 2018; 2018: 1471839.
– reference: 9) Kamada Y, Murayama Y, Ota U, Takahashi K, Arita T, Kosuga T, Konishi H, Morimura R, Komatsu S, Shiozaki A, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Tanaka T, Otsuji E. Urinary 5-Aminolevulinic Acid Concentrations as a Potential Tumor Marker for Colorectal Cancer Screening and Recurrence. Anticancer Res. 2016; 36: 2445-2450.
– reference: 8) Hoda MR, Popken G. Surgical outcomes of fluorescence-guided laparoscopic partial nephrectomy using 5-aminolevulinic acid-induced protoporphyrin IX. J Surg Res. 2009; 154: 220-225.
– reference: 14) Peng C, Li Y, Liang H, Cheng J, Li Q, Sun X, Li Z, Wang F, Guo Y, Tian Z, Yang L, Tian Y, Zhang Z, Cao W. Detection and photodynamic therapy of inflamed atherosclerotic plaques in the carotid artery of rabbits. J Photochem Photobiol B. 2011; 102: 26-31.
– reference: 6) Inoue K, Ota U, Ishizuka M, Kawada C, Fukuhara H, Shuin T, Okura I, Tanaka T, Ogura S. Porphyrins as urinary biomarkers for bladder cancer after 5-aminolevulinic acid (ALA) administration: the potential of photodynamic screening for tumors. Photodiagnosis Photodyn Ther. 2013; 10: 484-489.
– reference: 5) Nakai Y, Tatsumi Y, Miyake M, Anai S, Kuwada M, Onishi S, Chihara Y, Tanaka N, Hirao Y, Fujimoto K. Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancer. Photodiagnosis Photodyn Ther. 2016; 13: 225-232.
– reference: 10) Endo Y, Okayama A, Endo G, Ueda T, Nakazono N, Horiguchi S. Improvement of urinary delta-aminolevulinic acid determination by HPLC and fluorescence detection using condensing reaction with acetylacetone and formaldehyde. Sangyo Igaku. 1994; 36: 49-56.
– reference: 13) Tickoo SK, Lee MW, Eble JN, Amin M, Christopherson T, Zarbo RJ, Amin MB. Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol. 2000; 24: 1247-1256.
– reference: 2) 西本, 紘嗣郎,城 武卓,小山, 政史.5-アミノレブリン酸を用いた診断への取り組み(第45回尿路悪性腫瘍研究会講演スライド,2018年7月21日).2018. Available from: https://figshare.com/articles/5-________/7075235.
– reference: 7) Nakai Y, Anai S, Onishi S, Masaomi K, Tatsumi Y, Miyake M, Chihara Y, Tanaka N, Hirao Y, Fujimoto K. Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer. Photodiagnosis Photodyn Ther. 2015; 12: 282-288.
– reference: 4) Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992; 14: 275-292.
SSID ssib005901867
ssib002484516
ssj0052678
ssib000872012
Score 2.1802979
Snippet 5-アミノレブリン酸(ALA)の代謝産物であるプロトポルフィリンIX(PPIX)は正常組織に比べ腫瘍組織に高濃度に集積し,青色光で赤色の蛍光を発する.この特性を利用した...
SourceID jstage
SourceType Publisher
StartPage 93
SubjectTerms 5-アミノレブリン酸
光力学診断
尿中ポルフィリン
腎細胞癌
腫瘍マーカー
Title 腎細胞癌における5-アミノレブリン酸(5-ALA)を用いた光力学診断および5-ALA投与後の尿中ポルフィリン測定の有用性の検討
URI https://www.jstage.jst.go.jp/article/jslsm/40/1/40_jslsm-40_0014/_article/-char/ja
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本レーザー医学会誌, 2019/04/15, Vol.40(1), pp.93-103
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1881-1639
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0052678
  issn: 0288-6200
  databaseCode: KQ8
  dateStart: 19800101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NixRHFG9EL3qQGBPURPGQOoU2M11d3VXHqrEXSVQQVvAgDN2z04fBL-J6ySkz7YK7ykJCFJKYCGrMoq4IelhEkj-mnNn15L_ge6-qx95kD4kIQ_Om5tWv3kd19Xs9Xa-D4Iu-UgWPUhG2ylyEsZxrhZLnSVj2ylikpYjnSrw1cOJkcux0_PUZcWbbjrONp5auzBdHet9tua_kfbwKbeBX3CX7Pzw7BYUGoMG_cAQPw_E_-ZhlkknBZMaylJmYmRa1cKaoRSkmOyzjEC0ybTwhtSdUm4iISSNCT-qICACY8QRiE6E79U9J3aI9YTjLFApiJMtmmOkwKUWoj-v6m_LwKiKxYqZlLU1cSwMDClJGEaGZMkjoo0wnqBV0MQCY4PjQuEkZ0KEGNNyPnBCGYFmMYqEaIF_WMIhraTEz43k8KmhYE95onHCcgfhWyifUvUPyZkzpxhAgrzPAVO8EHy7R6SYeHSOb01JmzYSBEFKmhYeaumFKmI6XzSSNFoGamqYJY2xH2SQKL6d3x5EFrC-dIMQLpx0hHGWKN9nAWpL8ZNr4IbYE9TLOe-DtaBM_GKxNc4OjZh4WUFAMgb1U-o5fopaIVCtK_DSxlSQpU7K_cvOyeb-qTX-9uR27tMJgP7C6UQ2fKHSsIrfDHEJrCZw3WpEDY28tacjbCTrWTx8Nny8_uCMal-AIVpzE1dKFaMmFCFLiq9VdCa46hnAlxzatlS4g8G5yoWWbynn8K2qJBMfHfAeXz10-f4SOYYxFe93u6n-Ug_eLTZf4usDXxsP0G_bq1jy4cbM7gOxxRwQxD77Y5ptTzeQrjZrJThRL_9Zuf3WGVEEm09tXIvJxbW0TV8MNhf9qC9Ehoh9Afls_G0vh-uxHwW6fZx_WTsY9wbZB_nGwq1F9dW_wx8bC8vrzpxvV7-s_37DDR3a4ZIc_2NF1EdrRXVvdsdWyrR7b6patHtrq2euFtTcvr9Hy8ubloh39uP7Tih1etcM744XF8dKv49UHGysvJrdWEWh0zQ6fEe9k6earteXxXzDEk_HTv1-trdrqN1s9stVNO7rnoCdrj8dPfgGGye1FQJ18_yfS929vrCx_EszOZLOdY6F_a004aEuVhxzMxMskUlhlr2gJkfeiuCxK3irmRF5CvAQZUZ6346IPV0Lcw57ExVzeb_Xxhdycfxpsv3DxQn9fcJj3IRptlT04iUrIamVR9opU9fqQQvIS8vb9gXEm7l5ylYm67zE5DnwIkM-Cne9O9c-D7fPfXukfhGRtvjhEc-4taJJVrQ
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%85%8E%E7%B4%B0%E8%83%9E%E7%99%8C%E3%81%AB%E3%81%8A%E3%81%91%E3%82%8B5-%E3%82%A2%E3%83%9F%E3%83%8E%E3%83%AC%E3%83%96%E3%83%AA%E3%83%B3%E9%85%B8%EF%BC%885-ALA%EF%BC%89%E3%82%92%E7%94%A8%E3%81%84%E3%81%9F%E5%85%89%E5%8A%9B%E5%AD%A6%E8%A8%BA%E6%96%AD%E3%81%8A%E3%82%88%E3%81%B35-ALA%E6%8A%95%E4%B8%8E%E5%BE%8C%E3%81%AE%E5%B0%BF%E4%B8%AD%E3%83%9D%E3%83%AB%E3%83%95%E3%82%A3%E3%83%AA%E3%83%B3%E6%B8%AC%E5%AE%9A%E3%81%AE%E6%9C%89%E7%94%A8%E6%80%A7%E3%81%AE%E6%A4%9C%E8%A8%8E&rft.jtitle=%E6%97%A5%E6%9C%AC%E3%83%AC%E3%83%BC%E3%82%B6%E3%83%BC%E5%8C%BB%E5%AD%A6%E4%BC%9A%E8%AA%8C&rft.au=%E5%9F%8E%E6%AD%A6%2C+%E5%8D%93&rft.au=%E5%B0%8F%E5%B1%B1%2C+%E6%94%BF%E5%8F%B2&rft.au=%E5%B2%A1%E9%83%A8%2C+%E5%B0%9A%E5%BF%97&rft.au=%E8%A5%BF%E6%9C%AC%2C+%E7%B4%98%E5%97%A3%E9%83%8E&rft.date=2019-04-15&rft.pub=%E7%89%B9%E5%AE%9A%E9%9D%9E%E5%96%B6%E5%88%A9%E6%B4%BB%E5%8B%95%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E3%83%AC%E3%83%BC%E3%82%B6%E3%83%BC%E5%8C%BB%E5%AD%A6%E4%BC%9A&rft.issn=0288-6200&rft.eissn=1881-1639&rft.volume=40&rft.issue=1&rft.spage=93&rft.epage=103&rft_id=info:doi/10.2530%2Fjslsm.jslsm-40_0014&rft.externalDocID=article_jslsm_40_1_40_jslsm_40_0014_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0288-6200&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0288-6200&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0288-6200&client=summon